Prevalence of antibiotic use: a comparison across various European health care data sources-Reference-Cited by-同舟云学术

Prevalence of antibiotic use: a comparison across various European health care data sources

Published:2015-07-07 Issue:S1 Volume:25 Page:11-20
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Brauer Ruth¹^ORCID,Ruigómez Ana²,Downey Gerry³,Bate Andrew⁴,Garcia Rodriguez Luis Alberto²,Huerta Consuelo⁵,Gil Miguel⁵,Abajo Francisco⁶⁷,Requena Gema⁷,Alvarez Yolanda⁸,Slattery Jim⁸,Groot Mark⁹^ORCID,Souverein Patrick⁹,Hesse Ulrik¹⁰,Rottenkolber Marietta¹¹,Schmiedl Sven¹²¹³,Vries Frank⁹¹⁴¹⁵,Tepie Maurille Feudjo³,Schlienger Raymond¹⁶,Smeeth Liam¹,Douglas Ian¹,Reynolds Robert¹⁷,Klungel Olaf⁹

Affiliation:

1. Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine London UK

2. Fundación Centro Español de Investigación Farmacoepidemiológica (CEIFE) Madrid Spain

3. Amgen NV London UK

4. Epidemiology Pfizer Ltd Surrey UK

5. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) Madrid Spain

6. Clinical Pharmacology Unit University Hospital Príncipe de Asturias Madrid Spain

7. Pharmacology Section, Department of Biomedical Sciences II University of Alcalá (UAH) Madrid Spain

8. European Medicines Agency (EMA) London UK

9. Faculty of Science, Division of Pharmacoepidemiology and Clinical Pharmacology Utrecht University Utrecht The Netherlands

10. Lægemiddelstyrelsen (Danish Medicines Agency) National Institute for Health Data and Disease Control Copenhagen Denmark

11. Institute of Medical Information Sciences, Biometry, and Epidemiology Ludwig‐Maximilians‐Universitaet Muenchen Munich Germany

12. Department of Clinical Pharmacology, School of Medicine, Faculty of Health Witten/Herdecke University Witten Germany

13. Philipp Klee‐Institute for Clinical Pharmacology HELIOS Clinic Wuppertal Wuppertal Germany

14. MRC Lifecourse Epidemiology Unit Southampton General Hospital Southampton UK

15. School CAPHRI / Maastricht University Maastricht The Netherlands

16. Novartis Pharma AG Basel Switzerland

17. Epidemiology Pfizer Research & Development New York NY USA

Funder

Innovative Medicines Initiative Joint Undertaking

European Union's Seventh Framework Programme

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.3831

Reference25 articles.

1. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009);Adriaenssens N;J Antimicrob Chemother,2011

2. Antibiotic Prescription Rates Vary Markedly Between 13 European Countries

3. BjerrumL MA ReutskiyA LlorC CotsJM CaballeroL OvhedI StrandbergE RadzevicieneR Gahrn‐HansenB.Respiratory tract infections in general practice: total results 2008/2009 from 6 countries and 618/511 GPs. 2010.http://www.happyaudit.org/files/pub/4398.pdf. Accessed December 17 2012.

4. Clinical Practice ResearchDatalink.Observational data.http://www.cprd.com/ObservationalData/CodedData.asp#Primarycare. Accessed December 17 2012.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outpatient Antibiotic Use and Costs in Adults: A Nationwide Register-Based Study in Finland 2008–2019;Antibiotics;2022-10-22

2. Changes in Sensitization Patterns in the Last 25 Years in 619 Patients with Confirmed Diagnoses of Immediate Hypersensitivity Reactions to Beta-Lactams;Biomedicines;2022-06-28

3. Adsorption of a wide variety of antibiotics on graphene-based nanomaterials: A modelling study;Chemosphere;2022-06

4. Risk of ischaemic stroke among new users of glucosamine and chondroitin sulphate: a nested case–control study;Therapeutic Advances in Musculoskeletal Disease;2022-01

5. Differences in service and antibiotics use following symptomatic respiratory tract infections between 2016 and 2021 in rural Anhui, China;Epidemiology and Infection;2022